Skip to main content
logo
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.260
+0.010 (0.24%)
Apr 21, 2026, 2:18 PM EDT - Market open

ADC Therapeutics Revenue

In the year 2025, ADC Therapeutics had annual revenue of $81.36M with 14.85% growth. ADC Therapeutics had revenue of $23.06M in the quarter ending December 31, 2025, with 36.36% growth.

Revenue (ttm)
$81.36M
Revenue Growth
+14.85%
P/S Ratio
6.53
Revenue / Employee
$421,539
Employees
193
Market Cap
541.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202581.36M10.52M14.85%
Dec 31, 202470.84M1.28M1.84%
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE205.07M
4D Molecular Therapeutics85.21M
Fulcrum Therapeutics80.00M
Verastem30.91M
Upstream Bio2.85M
Revenue Rankings

ADCT News

More News